UBS AM’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.42M | Sell |
63,405
-27,372
| -30% | -$766K | ﹤0.01% | 2208 |
|
|
2026
Q1 | $3.32M | Buy |
90,777
+1,125
| +1% | +$44.4K | ﹤0.01% | 1783 |
|
|
2025
Q4 | $4.09M | Buy |
89,652
+5,085
| +6% | +$226K | ﹤0.01% | 1570 |
|
|
2025
Q3 | $3.58M | Sell |
84,567
-234,399
| -73% | -$8.83M | ﹤0.01% | 1518 |
|
|
2025
Q2 | $9.92M | Buy |
318,966
+5,572
| +2% | +$151K | ﹤0.01% | 1360 |
|
|
2025
Q1 | $7.7M | Sell |
313,394
-2,807
| -0.9% | -$78K | ﹤0.01% | 1360 |
|
|
2024
Q4 | $9.04M | Sell |
316,201
-24,686
| -7% | -$685K | ﹤0.01% | 1297 |
|
|
2024
Q3 | $9.07M | Buy |
340,887
+125,668
| +58% | +$3.27M | ﹤0.01% | 1277 |
|
|
2024
Q2 | $5.52M | Buy |
215,219
+171,910
| +397% | +$3.85M | ﹤0.01% | 1434 |
|
|
2024
Q1 | $916K | Hold |
43,309
| – | – | ﹤0.01% | 2057 |
|
|
2023
Q4 | $774K | Hold |
43,309
| – | – | ﹤0.01% | 2158 |
|
|
2023
Q3 | $657K | Hold |
43,309
| – | – | ﹤0.01% | 2171 |
|
|
2023
Q2 | $567K | Hold |
43,309
| – | – | ﹤0.01% | 2271 |
|
|
2023
Q1 | $567K | Buy |
43,309
+3,690
| +9% | +$47.1K | ﹤0.01% | 2271 |
|
|
2022
Q4 | $480K | Hold |
39,619
| – | – | ﹤0.01% | 2188 |
|
|
2022
Q3 | $548K | Hold |
39,619
| – | – | ﹤0.01% | 2307 |
|
|
2022
Q2 | $748K | Buy |
39,619
+5,301
| +15% | +$102K | ﹤0.01% | 2111 |
|
|
2022
Q1 | $734K | Hold |
34,318
| – | – | ﹤0.01% | 2291 |
|
|
2021
Q4 | $698K | Hold |
34,318
| – | – | ﹤0.01% | 2396 |
|
|
2021
Q3 | $765K | Hold |
34,318
| – | – | ﹤0.01% | 2294 |
|
|
2021
Q2 | $975K | Buy |
34,318
+14,297
| +71% | +$390K | ﹤0.01% | 2228 |
|
|
2021
Q1 | $452K | Sell |
20,021
-12,527
| -38% | -$306K | ﹤0.01% | 2416 |
|
|
2020
Q4 | $768K | Hold |
32,548
| – | – | ﹤0.01% | 2114 |
|
|
2020
Q3 | $601K | Sell |
32,548
-580
| -2% | -$11.1K | ﹤0.01% | 2055 |
|
|
2020
Q2 | $635K | Buy |
33,128
+1,914
| +6% | +$40.6K | ﹤0.01% | 2015 |
|
|
2020
Q1 | $528K | Sell |
31,214
-3,357
| -10% | -$86.1K | ﹤0.01% | 1958 |
|
|
2019
Q4 | $937K | Sell |
34,571
-3,968
| -10% | -$97.5K | ﹤0.01% | 1944 |
|
|
2019
Q3 | $1.05M | Buy |
38,539
+16,760
| +77% | +$475K | ﹤0.01% | 1924 |
|
|
2019
Q2 | $652K | Buy |
21,779
+8,687
| +66% | +$258K | ﹤0.01% | 2084 |
|
|
2019
Q1 | $382K | Buy |
13,092
+913
| +7% | +$26K | ﹤0.01% | 2215 |
|
|
2018
Q4 | $346K | Hold |
12,179
| – | – | ﹤0.01% | 2145 |
|
|
2018
Q3 | $429K | Hold |
12,179
| – | – | ﹤0.01% | 2150 |
|
|
2018
Q2 | $339K | Hold |
12,179
| – | – | ﹤0.01% | 2254 |
|
|
2018
Q1 | $244K | Buy |
12,179
+12,000
| +6,704% | +$229K | ﹤0.01% | 2299 |
|
|
2017
Q4 | $3.43K | Hold |
179
| – | – | ﹤0.01% | 2539 |
|
|
2017
Q3 | $4.06K | Hold |
179
| – | – | ﹤0.01% | 2484 |
|
|
2017
Q2 | $3.57K | Hold |
179
| – | – | ﹤0.01% | 2475 |
|
|
2017
Q1 | $2.98K | Hold |
179
| – | – | ﹤0.01% | 2426 |
|
|
2016
Q4 | $3K | Buy |
+179
| New | +$3.26K | ﹤0.01% | 2432 |
|
Other funds holding AORT
NAMI
JIC
OAM
PA
CCA
UBS AM's AORT Position: Q2 2026 in Review
UBS AM reduced its Artivion (AORT) stake by 30% in Q2 2026, selling an estimated $766K and leaving 63,405 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2208.
UBS AM first reported a position in AORT in Q4 2016 and has held it in 39 quarters since. The position peaked at $9.92M in Q2 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.
- UBS AM held 63,405 shares of Artivion worth $1.42M as of Q2 2026.
- UBS AM sold 27,372 Artivion shares in Q2 2026, an estimated $766K.
- Artivion made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2208 holding.
- UBS AM first reported a position in Artivion in Q4 2016 and has held it in 39 quarters since.
- UBS AM's Artivion position peaked at $9.92M in Q2 2025.
- 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.